Literature DB >> 2583313

[Cellular immune dysfunction in the NOD mouse: suppression of concanavalin A-induced responses in spleen cells by activated macrophages].

Y Kawase1, K Yokono, M Nagata, N Hatamori, H Akiyama, T Sakamoto, K Yonezawa, S Yaso, K Shii, S Baba.   

Abstract

It is generally accepted that T lymphocyte-mediated autoimmunity contributes to the pathogenesis of Type 1 diabetes in humans and animals. Using spleen cells from nonobese diabetic (NOD) mice, a model of human Type 1 diabetes, we have analyzed the subset of T lymphocytes by flow cytometry and investigated concanavalin A (Con A)-induced interleukin 2 (IL-2) production and cell proliferation. NOD mice showed a higher percentage of Thy1.2+, L3T4+, and Lyt2+ T lymphocytes than did control ICR mice through the whole age examined. Spleen cells from a large majority of NOD mice were found to generate very low IL-2 production and cell proliferation in response to Con A. However, a few mice preserved their responsiveness to Con A. The following reasons may indicate that macrophage-mediated suppression participates in the deficient function of NOD spleen cells. (a) Macrophage depletion from NOD spleen cells retrieved Con A-induced IL-2 production. (b) Thioglycollate-induced peritoneal exudate cells containing many activated macrophages could completely suppress cell proliferation. (c) Prostaglandin synthetase inhibitor indomethacin reversed the suppression of IL-2 production by macrophages. (d) Conversely, exogenous prostaglandins could show the partial suppression of IL-2 production. These results suggest that activated macrophages suppress the response of NOD spleen cells to Con A mostly through prostaglandins. This impairment may contribute to the pathogenesis of Type 1 diabetes in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583313     DOI: 10.1507/endocrine1927.65.7_674

Source DB:  PubMed          Journal:  Nihon Naibunpi Gakkai Zasshi        ISSN: 0029-0661


  1 in total

1.  Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Authors:  S A Litherland; X T Xie; A D Hutson; C Wasserfall; D S Whittaker; J X She; A Hofig; M A Dennis; K Fuller; R Cook; D Schatz; L L Moldawer; M J Clare-Salzler
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.